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| INTRODUCTION
Marrow stromal cells (MSCs), also known as bone marrow-derived mesenchymal progenitor cells, have the potential to differentiate into various kinds of cell types, eg, osteoblasts, chondrocytes, adipocytes and myoblasts. 1 Normally, there exists a reciprocal balance between adipogenesis and osteogenesis, 2, 3 which is sometimes impaired in various human disorders including ageing, osteoporosis and obesity, etc. 4, 5 It is crucial to elucidate the mechanisms that fine tune the balance between osteogenic and adipogenic differentiation.
A number of critical signalling pathways are involved in regulating the osteogenic and adipogenic commitment of MSCs, including transforming growth factor-β (TGF-β)/bone morphogenetic protein (BMP) signalling, canonical Wnt signalling, Notch and Hedgehogs, etc. [6] [7] [8] [9] Besides, multiple transcription factors are critical for the differentiation of MSCs into adipocytes or osteoblasts. While runt-related transcription factor 2 (Runx2) and Osterix are required for osteogenic differentiation, 10, 11 CCAAT element binding protein (C/ EBP) members and peroxisome proliferator-activated receptor γ (PPARγ) play a role in adipogenic differentiation of MSCs. 12, 13 Epigenetic regulation of gene expression through histone modifications is attracting more attention as the player in lineage-specific commitment of progenitor cells. [14] [15] [16] Histone modifications occur usually at lysine and arginine residues, and may alter histone-DNA binding affinities and the interactions of specific transcription factors with the promoters. 17 Histone demethylases are the classes of enzymes that remove methyl groups in modified histone proteins.
Although largely unknown, recent emerging evidences have shown that histone demethylases may exert essential regulatory functions in cell fate decision of MSCs. 18 Ye et al have demonstrated that the histone demethylases KDM4B and KDM6B play a positive role in osteogenic commitment of MSCs at the expense of adipogenic differentiation. 19 The mechanism investigations showed that KDM6B increased the levels of homeobox (HOX) genes by removing H3K27me3, whereas KDM4B promoted the expression of distal-less homeobox (DLX) genes by removing H3K9me3. 19 Of interest, H3K27me3-and H3K9me3-positive MSCs of bone marrow were significantly increased in ovariectomized and ageing mice in parallel with the highly active adipogenesis. 19 Furthermore, KDM5A and KDM2A have also been recognized as osteogenic regulators, both of which negatively regulated osteogenic differentiation of MSCs. 20, 21 The mechanism exploration revealed that KDM5A decreased the expression level of Runx2 through removing H3K4me3 levels from the promoter of Runx2, 20 whereas KDM2A enhanced secreted frizzled-related protein 2 (Sfrp2) transcription by decreasing histone H3K4 and H3K36 methylation at the Sfrp2 promoter. 21 The histone lysine(K)-specific demethylase 7 (KDM7) subfamily is an emerging class of transcriptional coactivators that consists of three members, KDM7A, KDM7B and KDM7C. While KDM7B plays an essential role in neuronal differentiation, craniofacial development and tumour growth, 22, 23 KDM7C is involved in various biological processes including osteogenesis and adipogenesis. In osteoblasts, KDM7C promotes DNA binding of Runx2 by directly demethylating mouse Runx2 at Lys245 or human Runx2 at Lys238, rather than by demethylating histones on Runx2 target genes. 24 During adipogenesis, KDM7C physically interacts with C/EBPα and C/EBPδ and epigenetically boosts the C/EBP-driven expression of adipogenic factors. 25 Histone lysine demethylase 7A (KDM7A), also known as JHDM1D, is a member of the plant homeodomain (PHD) finger protein (PHF) family of PHD-and JmjC domain-containing histone demethylases. It is able to catalyse the removal of di-methylation marks H3K9m2 and H3K27m2 on the promoters of target genes, 26 and through this, regulates fibroblast growth factor-4 (FGF-4) expression and neural differentiation. 27 KDM7A also functions as a potential tumour suppressor through blocking tumour growth and angiogenesis. 28 Up to now, it remains unknown if KDM7A regulates adipogenic and osteogenic commitment of mesenchymal stem cells.
In this study, we identified KDM7A as a player in adipogenic and osteogenic differentiation from progenitor cells. Mechanism studies revealed that this is based upon the stimulation of C/EBPα and Sfrp1 transcription as a result of the removal of the repressive H3K9me2
and H3K27me2 marks by KDM7A from the promoter regions of C/ EBPα and Sfrp1.
| MATERIALS AND METHODS

| Cell cultures
Stromal ST2 cells were obtained from Riken Cell Bank (Tsukuba, Japan), and maintained in DMEM containing 10% FBS. Bone marrow stromal cells (BMSCs) were isolated from femurs and tibias of 4-week-old C57BL/6J mice and cultured in αMEM containing 10% foetal bovine serum. For adipogenic differentiation, confluent cells were cultured in adipogenic medium (a-MEM containing 10% FBS, 0.5 μmol/L dexamethasone, 0.25 mmol/L methylisobutylxanthine, 5 μg/mL insulin and 0.5 mmol/L indomethacin) for 72 hours, followed by treatment for an additional 48 hours with 5 μg/mL insulin alone.
For osteogenic differentiation, 80% confluent cells were cultured in osteogenic medium (αMEM containing 10% FBS, 50 μg/mL ascorbic acid and 5 mmol/L β-glycerophosphate) for 3 days followed by RNA and protein isolation, or for 14 days followed by alkaline phosphatase (ALP) staining.
| Quantitative RT-PCR
RNA was extracted using a total RNA isolation kit (Gmbiolab, Taiwan). After reverse transcription with 1 μg of the total RNA and random primers, the cDNA was PCR-amplified on a real-time PCR cycler using a SYBR Green fluorescence PCR kit (Sangon Biotech, Shanghai, China) with gene specific primers. RT-PCR amplifications were carried out for one cycle of 95°C for 10 minutes, followed by 40 cycles of 95°C for 10 seconds, 57°C for 10 seconds and 72°C for 10 seconds. β-actin was used as internal control. The expression levels of target genes were measured by the comparative Ct (ΔΔCt) method. The sequences of the primers are listed in Table S1 . 
| Constructs and transfections
| Lentiviral packaging and infection
To make the Kdm7a shRNA coding construct, two complementary 
| Oil-red O staining
Differentiated adipocytes were fixed in 4% paraformaldehyde, then washed with deionized water. After incubating with 60% isopropanol for 2 minutes, the cells were stained with oil-red O solution (0.5% oil red O in isopropanol/water = 3:2) for 5 minutes. For oil-red O quantification, isopropanol was added to dissolve the stain. Light absorbance was measured at 520 nm.
| ALP staining
Differentiated osteoblasts were fixed in 4% paraformaldehyde for 10 minutes, and then stained with the 1-Step nitroblue tetrazolium (NBT)/5-bromo-4-chloro-3-indolyl phosphate (BCIP) staining kit (Sangon Biotech, Shanghai, China) for 15 minutes.
| Western blot analysis
Proteins were separated by SDS-PAGE and transferred onto nitrocel- Park, CA, USA) was finally used to visualize the results.
| Chromatin immunoprecipitation (ChIP) assay
Chromatin immunoprecipitation (ChIP) assay was performed using a Table S1 .
| Statistical analysis
Data are expressed as means ± SD. For the relative mRNA expression analysis, the means of the control groups were set to 1. Statistical analysis was performed with the independent t test or one-way ANOVA. If the one-way ANOVA result was significant, a post hoc comparison was performed with the least significant difference (LSD) test. A value of P < 0.05 indicated statistical significance.
| RESULTS
| Kdm7a was expressed in bone and adipose tissue and increased during osteoblast and adipocyte differentiation
We examined the expression levels of Kdm7a in various tissues in 1-month-old mice. Kdm7a mRNA was highly expressed in bone and skeletal muscle, and moderately expressed in spleen and heart. | 2151 during osteogenic differentiation ( Figure 1D,E) . These results suggest that KDM7A has a regulatory role in adipogenic and/or osteogenic differentiation. By contrast, the Kdm7a siRNAs positively affected the differentiation of ST2 cells into osteoblasts, revealed by enhanced ALP staining ( Figure 2F ). Consistently, the mRNA levels of Runx2, Osterix, Alp, Osteopontin (Opn) and Osteocalcin (Oc) were increased 72 hours after osteogenic treatment ( Figure 2G ). Moreover, the protein levels of Runx2, Osterix, ALP and Osteopontin were also substantially increased 72 hours after osteogenic treatment ( Figure 2H ).
| Silencing of endogenous
| Kdm7a overexpression in ST2 cells induced adipocyte formation and inhibited osteoblast differentiation and the effect is dependent on its demethylase activity
In order to further demonstrate whether KDM7A regulates adipogenic and osteogenic differentiation and whether this is dependent on its demethylase activity, we generated a wild-type construct and a catalytically dead Kdm7a mutant in which histidine 282 was changed to alanine, disrupting the non-haem metal binding site required for its demethylase activity. The overexpression of wild-type or mutant Kdm7a in ST2 cells was verified with qRT-PCR ( Figure 3A) . In presence of adipogenic medium, wild-type Kdm7a overexpression significantly increased the number of differentiated adipocytes, while the effect was largely attenuated when we overexpressed mutant Kdm7a
( Figure 3B,C) . Accordingly, wild-type Kdm7a induced the mRNA and protein levels of adipogenic transcription factors and marker genes 48 and 72 hours, respectively, after adipogenic treatment, whereas the effect of mutant Kdm7a was largely attenuated (Figure 3D,E) .
Conversely, in the presence of osteogenic medium, wild-type Kdm7a overexpression in ST2 cells inhibited osteoblast differentiation whereas the effect was largely attenuated when the mutant Kdm7a was overexpressed, as evidenced by ALP staining ( Figure 3F ).
Consistently, wild-type Kdm7a decreased the mRNA and protein levels of osteogenic factors 72 hours after osteogenic treatment, whereas the effect of mutant Kdm7a was largely attenuated (Figure 3G ,H). These data suggest that the demethylase function of KDM7A is required for stimulation of adipogenic differentiation and suppression of osteogenic differentiation.
| Kdm7a knock-down in primary MSCs inhibited adipogenic differentiation and stimulated osteogenic differentiation
To 
| KDM7A targets C/EBPα and canonical Wnt signalling to regulate ST2 cells differentiation through removing H3K9me2 and H3K27me2
The commitment of MSCs is regulated by a complex and highly orchestrated gene expression program and many developmental signalling pathways. To further explore the mechanisms through which KDM7A regulates adipogenic and osteogenic differentiation, we tested whether the disruption of KDM7A affected the endogenous expression of key regulators of progenitor cells. Intriguingly, after depletion of Kdm7a, the basal levels of endogenous C/EBPα and Sfrp1 were significantly suppressed. By contrast, Kruppel-like factor 7 (Klf7) was not affected, whereas C/EBPβ, PPARγ and Kruppel-like factor 9 (Klf9) were even up-regulated after silencing of Kdm7a ( Figure 5A ). Consistently, the protein levels of C/EBPα and SFRP1
were also decreased after silencing of Kdm7a (
Figure 5B 
| DISCUSSION
Histone lysine(K)-specific demethylase 7A (KDM7A) has been characterized as being capable of removing di-methylation marks of histone H3K9 and H3K27. 30 However, the biological function of KDM7A in cell behaviour needs to be further explored. In this study, the mRNA expression levels of Kdm7a were examined in various tissues in mice. Kdm7a was highly expressed in bone and skeletal muscle. Moreover, we found that the mRNA expression of Kdm7a increased in progenitor cells during adipogenesis and osteogenesis.
The data suggest that KDM7A may play a role in adipocyte and osteoblast differentiation.
To clarify the precise role of KDM7A in cell fate decision, we tested the effects of KDM7A on osteogenic and adipogenic differentiation. The data showed that the depletion of Kdm7a in undifferentiated progenitor cells inhibited the formation of adipocytes whereas stimulated the differentiation of osteoblasts. Conversely, overexpression of Kdm7a induced formation of adipocytes whereas blocked differentiation of osteoblasts. The anti-osteogenic function seems to be contradictory to the observation that Kdm7a expression increased during osteogenic differentiation. This pattern is similar to the case of LncRNA H19, which was induced during myoblast differentiation, but exhibited an inhibitory effect on muscle differentiation. 31 The increase in Kdm7a during osteoblast differentiation might be interpreted as a self-balancing mechanism of cells to limit excessive osteogenesis. Of more interest, the effect of KDM7A on differentiation was largely attenuated when the catalytically dead mutation was made. These findings provide evidences that KDM7A reciprocally regulates osteoblast and adipocyte differentiation from progenitor cells and the regulation requires its action to demethylate the histones.
The effect of methylation status on transcription depends on the exact residue targeted and the degree of methylation. Trimethylation of H3K4, H3K36 and H3K79 is a representative marker for euchromatin, which is loosely packed, so accessible for transcription factors. In contrast, mono-methylation of H4K20, and di-/tri-methylation of H3K9 or H3K27 mark heterochromatin, which is too tightly packed to be accessed by transcription factors. 24, 25 Thus H3K4me2/3 and H3K79me3 usually correlate with transcriptional activation, whereas H3K9me2/3, H3K27me2/3 and H4K20me3 are preferentially associated with transcriptional repression. 16, 32, 33 The KDM7 subfamily members can demethylate In summary, our work has identified novel KDM7A functions as a reciprocal regulator of osteogenesis and adipogenesis. The function is based upon its epigenetic regulation of SFRP1 and C/ EBPα. Our study provides insights into the epigenetic mechanisms underlying the lineage commitment of MSCs. These findings may contribute to new therapeutic clues for metabolic disorders such as osteoporosis.
